With $60M, new acquisition, Peninsula company looks to deepen genome insights
Hoping to help more patients unlock the mysteries of the full package of genetic material within them, a Peninsula company doubled the amount of money it had raised and made its first acquisition.
Genome Medical Inc. raised $60 million in a Series C round including new investors GV — the former Google Ventures — and the venture capital unit of biotech giant Amgen Inc.
The South San Francisco company simultaneously bought Minneapolis-based GeneMatters, a telehealth genetic counseling a nd software…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Biotechnology | Genetics | Health Management | Mergers and Aquisitions | Pharmaceuticals | Venture Capital